[1]
Wendtner, C.-M. 2009. Consolidation therapy with alemtuzumab prolongs remission of chronic lymphocytic leukaemia. Hematology Meeting Reports (formerly Haematologica Reports). 1, 5 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v1i5.636.